Aldeyra Therapeutics Announces Confirmation of Antiviral Activity of ADX-1612
Business Wire
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced confirmation of SARS-CoV-2..
Max Delbrück Center for Molecular Medicine in the Helmholtz Association
News and Video Search Results
News coverage